15 December 2020 in Radiology
Combined US-triggered microbubble destruction and hepatocellular carcinoma radioembolization showed improved treatment response compared with radioembolization alone and no changes in vital signs o... Background US contrast agents are gas-filled microbubbles (MBs) that can be locally destroyed by using external US. Among other bioeffects, US-triggered MB destruction, also known as UTMD, has been...
1 March 2023 in Diagnostic and Interventional Radiology
PURPOSE The purpose of this study was to analyze and compare the outcomes of percutaneous microwave ablation (MWA) when used as a primary vs. secondary treatment for hepatocellular carcinoma (HCC). METHODS The clinical data of 192 patients with HCC treated with MWA between January 2012 and July 2021 were reviewed retrospectively, with 152 patients being treatment naive (primary treatment) vs. 40 who had residual or recurrent disease following previous trans-arterial chemoembolization or trans-arterial radioembolization (secondary treatment). The primary outcomes were primary tech-nical efficacy, 1-and 3-year local recurrence-free survival (RFS) and overall survival (OS), local recur-rence rates, and adverse events. Pre-and post-intervention liver function tests were compared us-ing a Wilcoxon signed rank test. Univariate and multivariate analyses were also performed, looking at prognostic factors associated with OS and local RFS.RESULTS There was no significant difference in 1-year local RFS (primary 93.6% vs. secondary 93.7; P = 0.97) and 3-year local RFS (primary 80.6% vs. secondary 86.5%; P = 0.37) rates. There was no significant difference in 1-year OS (primary 82.4% vs. secondary 86.6%; P = 0.51) and 3-year OS (primary 68.3% vs. secondary 77.4%; P = 0.25) between the two groups. The local recurrence rate (primary 9.8% vs. secondary 14.6%; P = 0.37), primary technical efficacy (primary 96.2% vs. secondary 95%; P = 0.73), and adverse events (primary 8.0% vs. secondary 11.6%; P = 0.45) were also similar between the two groups.CONCLUSION Microwave ablation is safe and effective as a secondary treatment for patients with HCC in a clinical salvage scenario and should be utilized more frequently.
19 August 2025 in Radiology Case Reports
Bilateral medial medullary infarction (BMMI) is a rare type of brainstem ischemic stroke involving the anteromedial medulla oblongata bilaterally. Diagnosis is often delayed due to its rarity, non-specific clinical presentation, and non-revealing imaging in the early phases. MRI plays a crucial role in early detection by revealing characteristic patterns. We report two cases of BMMI, highlighting classic and additional magnetic resonance imaging (MRI) findings and their anatomic correlations.
27 January 2026 in Radiology Case Reports
This case report follows a 60-year-old female with a history of hypertension, diabetes, and Factor V Leiden mutation with multiple prior deep vein thromboses (DVT) in the lower extremities who presented with right eye vision loss. Computed tomography angiogram (CTA) of the neck showed a 4 vessel arch anatomy with an absence of the left common carotid artery and separate origins of the left internal and external carotid arteries directly arising from the arch, which was an incidental finding. This case contributes to the sparse existing literature and highlights the extremely rare occurrence of complete carotid artery agenesis and its clinical implications.
11 January 2022 in Digestive Disease Interventions
Locoregional therapies (LRTs) are an essential management tool in the treatment of primary liver cancers or metastatic liver disease. LRTs include curative and palliative modalities. Monitoring treatment response of LRTs is crucial for maximizing benefit and improving clinical outcomes. Clinical use of contrast-enhanced ultrasound (CEUS) was introduced more than two decades ago. Its portability, cost effectiveness, lack of contraindications and safety make it an ideal tool for treatment monitoring in numerous situations. Two-dimensional dynamic CEUS has been proved to be equivalent to the current imaging standard in the guidance of LRTs, assessment of their adequacy, and detection of early tumor recurrence. Recent technical advances in ultrasound transducers and image processing have made 3D CEUS scanning widely available on most commercial ultrasound systems. 3D scanning offers a broad multiplanar view of anatomic structures, overcoming many limitations of two-dimensional scanning. Furthermore, many ultrasound systems provide real-time dynamic 3D CEUS, also known as 4D CEUS. Volumetric CEUS has shown to perform better than 2D CEUS in the assessment and monitoring of some LRTs. CEUS presents a valid alternative to the current imaging standards with reduced cost and decreased risk of complications. Future efforts will be directed toward refining the utility of 4D CEUS through approaches such as multi-parametric quantitative analysis and machine learning algorithms.
15 April 2026 in Radiology Case Reports
Acute pyelonephritis (APN) is characterized as infection of the renal parenchyma and collecting system generally evaluated by integrating clinical assessment, blood tests, urinalysis, and urine culture. If complications are suspected, computed tomography (CT) is the preferred modality; however, if inconclusive or contraindicated, magnetic resonance imaging (MRI) can provide valuable diagnostic information, though less well-described in literature. Herein, we report 2 cases in which MRI demonstrated restricted diffusion in the kidneys, corresponding to APN. In the first case, MRI confirmed findings established by CT (acute lobar nephronia); in the other, MRI provided primary diagnostic evidence of APN after indeterminate CT and US in a patient with prior history of acute pyelonephritis.